However, while TIMP-1 engagement of CD74 was found to induce internalization and signaling in lymphoma and breast cancer cells, the interaction between TIMP-1 and CD74 in immune and vascular cells has not been studied, and the impact of this ligand/receptor axis in vascular inflammation has remained unclear. This evidence concerns the gene TIMP1 and breast cancer.